EX1.AX
Price:
$0.011
Market Cap:
$1.93M
Exopharm Limited, a clinical-stage company, develops transformative medicines based upon extracellular vesicles (EVs) in Australia. The company's technology includes extracellular vesicle positioning system that allows specific molecules to be attached to the surface of exosomes to guide them to target tissues or cell types; leveraging oligonucleotide packing for amplified dosing, which enables specific RNA molecules to be preferentially loaded into exosomes as a therapeutic cargo; ligand-based exosome affinity purification that isolates and purifies exosomes from biofluids like blood and cell culture media. Its engineered EVs products comprise Fortrexo CoV for the treatment of SARS-CoV-2 in...[Read more]
Industry
Biotechnology
IPO Date
2018-12-17
Stock Exchange
ASX
Ticker
EX1.AX
According to Exopharm Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.12. This represents a change of -68.69% compared to the average of -0.39 of the last 4 quarters.
The mean historical PE Ratio of Exopharm Limited over the last ten years is -30736.70. The current -0.12 PE Ratio has changed -99.96% with respect to the historical average. Over the past ten years (40 quarters), EX1.AX's PE Ratio was at its highest in in the June 2023 quarter at -0.10. The PE Ratio was at its lowest in in the December 2015 quarter at -96178.86.
Average
-30736.70
Median
-11.69
Minimum
-192357.72
Maximum
-0.22
Discovering the peaks and valleys of Exopharm Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 87.20%
Maximum Annual PE Ratio = -0.22
Minimum Annual Increase = -99.68%
Minimum Annual PE Ratio = -192357.72
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -0.22 | -90.28% |
| 2022 | -2.27 | -76.74% |
| 2021 | -9.77 | 91.93% |
| 2020 | -5.09 | -56.44% |
| 2019 | -11.69 | -95.69% |
| 2018 | -271.02 | -99.68% |
| 2017 | -83752.21 | -56.46% |
| 2016 | -192357.72 | 87.20% |
The current PE Ratio of Exopharm Limited (EX1.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.09
5-year avg
-5.81
10-year avg
-30736.70
Exopharm Limited’s PE Ratio is greater than Hexima Limited (-2.30), greater than Wellfully Limited (-0.18), greater than The Sustainable Nutrition Group Ltd (-0.22), less than Health House International Limited (0), greater than Regeneus Ltd (-2.18), less than Jayex Technology Limited (-0.07), greater than Uscom Limited (-0.71), less than Total Brain Limited (-0.01), greater than Allegra Medical Technologies Limited (-0.83), greater than Medibio Limited (-1.21),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.30 | $2.17M | |
| -0.18 | $1.48M | |
| -0.22 | $1.41M | |
| 0 | $891.13K | |
| -2.18 | $3.68M | |
| -0.07 | $281.28K | |
| -0.71 | $3.12M | |
| -0.01 | $267.44K | |
| -0.83 | $3.47M | |
| -1.21 | $4.55M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exopharm Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Exopharm Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Exopharm Limited's PE Ratio?
How is the PE Ratio calculated for Exopharm Limited (EX1.AX)?
What is the highest PE Ratio for Exopharm Limited (EX1.AX)?
What is the 3-year average PE Ratio for Exopharm Limited (EX1.AX)?
What is the 5-year average PE Ratio for Exopharm Limited (EX1.AX)?
How does the current PE Ratio for Exopharm Limited (EX1.AX) compare to its historical average?